Charlotte Casebourne

Charlotte Casebourne Stock is a dedicated advocate for equal access to effective therapies in the healthcare industry.

She boasts an impressive educational background having studied at Sir William Borlase's Grammar School, obtaining an MPhil in Bioscience Enterprise from the University of Cambridge, and earning a First Class Honours Bachelor's degree in Biomedical Sciences from King's College London.

Charlotte is the CEO and Co-Founder of Theolytics, a significant role that underscores her leadership and entrepreneurial prowess.

In addition to her role at Theolytics, Charlotte has held influential positions in various organizations including serving as a Board Member of the UK BioIndustry Association.

Her previous experiences include being a Co-Founder and Director at New Medicine Partners, a Curator at the Global Shapers Network of the World Economic Forum, and a Managing Director and Founder of the London Hub at HealthTech Women.

Moreover, Charlotte has contributed her expertise as the Chair for Healthcare and Medical Technologies at Hello Tomorrow, a community that focuses on challenges in the healthcare industry.